SEC Form 4 · accession 0001055726-18-000016
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Bickerstaff
Director
Period of report
Mar 21, 2018
Accepted (ET)
Mar 22, 2018 · 2:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 21, 2018 | M | 4,090 | — | A | 4,090 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | — | Mar 21, 2018 | M | 4,090 | D | — | — | Common Stock | 4,090 | 8,180 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,270 restricted stock units is as follows: 4,090 shares vested on March 21, 2018; 4,090 shares will vest on March 21, 2019; 4,090 shares will vest on March 21, 2020. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.